Position in PRTA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$547,221
+$9,054 QoQ
Shares Held
55,896
+1.0% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 187 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in PRTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. PRTA ranks #175 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in PRTA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $547,221 | 55,896 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $538,167 | 55,367 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $539,832 | 56,527 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $605,529 | 62,042 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $382,440 | 63,005 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $817,727 | 66,079 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $929,542 | 67,115 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,103,176 | 65,940 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,439,763 | 69,756 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,572,895 | 63,500 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,250,172 | 61,920 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,013,260 | 62,451 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,150,741 | 60,790 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,706,758 | 55,844 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,995,509 | 49,718 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,843,001 | 46,891 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,175,730 | 43,305 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,547,386 | 42,313 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,194,496 | 44,423 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,163,609 | 44,414 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,181,788 | 42,439 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,482,708 | 59,025 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $797,403 | 66,395 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $612,436 | 61,305 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $714,951 | 68,351 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $843,352 | 78,818 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||